Acurex Biosciences
About
No comments yet. Be the first to share your take.
What does Acurex Biosciences do?
Acurex Biosciences is a biotechnology company focused on developing novel therapeutics for neurological disorders, with a particular emphasis on Parkinson's disease. The company leverages scientific advancements to create new medicines. They have announced receiving a grant from Aligning Science Across Parkinson’s (ASAP) in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support their research.
How much funding has Acurex Biosciences raised?
Acurex Biosciences has raised a total of $1M in funding. The most recent round on record is Grant.
Where is Acurex Biosciences headquartered?
Acurex Biosciences is headquartered in San Carlos, California, USA.
When was Acurex Biosciences founded?
Acurex Biosciences was founded in 2019.
What industry does Acurex Biosciences operate in?
Acurex Biosciences operates in Biotechnology, Pharmaceuticals, Neuroscience, Healthcare, Biotech, Drug Discovery.
What is Acurex Biosciences's current status?
Acurex Biosciences's current operating status is: Inactive.
What is Acurex Biosciences's revenue?
StartupHub estimates Acurex Biosciences's annual revenue at $116K (range $32K to $380K, 37% confidence), based on comparable companies in the sector.
What is Acurex Biosciences's valuation?
StartupHub estimates Acurex Biosciences's effective valuation at $3.7M (range $2.5M to $6.0M, 11% confidence), based on comparable companies in the sector.